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Abstract 
Brain imaging is now ubiquitous in clinical practice and research. The case for bringing 
together large amounts of image data from well-characterised healthy subjects and those with 
a range of common brain diseases across the life course is now compelling. This report follows 
a meeting of international experts from multiple disciplines, all interested in brain image 
biobanking. The meeting included neuroimaging experts (clinical and non-clinical), computer 
scientists, epidemiologists, clinicians, ethicists, and lawyers involved in creating brain image 
banks. The meeting followed a structured format to discuss current and emerging brain image 
banks; applications such as atlases; conceptual and statistical problems (e.g. defining 
‘normality’); legal, ethical and technological issues (e.g. consents, potential for data linkage, 
data security, harmonisation, data storage and enabling of research data sharing). We 
summarise the lessons learned from the experiences of a wide range of individual image banks, 
and provide practical recommendations to enhance creation, use and reuse of neuroimaging 
data. Our aim is to maximise the benefit of the image data, provided voluntarily by research 
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participants and funded by many organisations, for human health. Our ultimate vision is of a 
federated network of brain image biobanks accessible for large studies of brain structure and 
function. 
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1. Introduction 
Neuroimaging has become embedded in substantial research endeavours to understand 
normal brain function and effects of disease (e.g. Thompson et al., 2003; Fox and Schott, 
2004; Lemaitre et al., 2005; Marcus et al., 2009; Wardlaw et al., 2011; Weiner et al., 2016). 
Until recently, many neuroimaging studies were in single centres and, inevitably, of modest 
size (Dickie et al., 2012).  Many much larger population scanning initiatives are now ongoing 
(Jack Jr et al., 2008), and many multicentre clinical trials routinely include imaging as part of 
inclusion criteria and as outcome measures (Cash et al., 2014), providing the potential for 
large multicentre collections capturing the range of brain structure in the population. The 
importance of maximising the value captured in this large amount of imaging data – to detect 
how differences in brain structure and function relate to behavioural or clinical outcomes – is 
now widely recognised (Toga, 2002; Barkhof, 2012; Poline, 2012). The value of data for 
answering new questions can grow with sample size, e.g. for replication, increasing 
population representativeness, and increasing study power. To address this issue, a growing 
number of electronic databanks including brain imaging are available, either from dedicated 
cohorts (e.g. Alzheimer's Disease Neuroimaging Initiative, UK Biobank, IMAGEN), or 
collections of studies (e.g. Brain Imaging in Normal Subjects, Dementia Platform UK, Open 
Access Series of Imaging Studies): see Table 1.  
 
Brain images from ‘healthy’ subjects are important: The wide variation in brain structure and 
function both within and between individuals at different ages has long been recognised 
(Wardlaw et al., 2011; Dickie et al., 2013). Methodologies that use appropriately 
representative populations are needed to provide normative populations, particularly for 
healthy subjects (i.e. those without neurological diseases such as stroke or dementia). They 
can provide informative reports for users (e.g. ‘brain on 5th percentile for volume at age 70’ 
for a specified population) and simultaneously embrace the spectrum of individual variation 
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(Dickie et al., 2015a, 2015b). Brain imaging is increasingly used in the diagnosis of 
neurological diseases, and mental health disorders (Fox and Schott, 2004). Data from existing 
cohort or population studies (e.g. Marcus et al., 2009), can help define boundaries between 
health and disease, to aid diagnosis and trial inclusion, to provide effect size estimates for 
planning trials, and, where relevant, controls for case-control studies (e.g. Dickie et al., 
2015a; ADNI: Potvin et al., 2016). 
  
Current status of brain imaging banks: Large repositories of brain imaging data from well-
characterised subjects in accessible databanks are required to achieve this, while ensuring that 
data protection concerns are also addressed. These comprise data initiatives that are planned 
around harmonised protocols, such as ADNI (Alzheimer's Disease Neuroimaging Initiative) 
(Weiner et al., 2015), UK Biobank (Matthews & Sudlow, 2016), Human Connectome Project 
(van Essen, 2013), OASIS (Open Access Series of Imaging Studies) (Marcus et al., 2007a, 
2007b, 2009), and those that represent data aggregation without initial harmonisation e.g. 
ENIGMA 
(Enhancing Neuro Imaging Genetics through Meta-Analysis - Thompson et al., 2014, 2015). 
The value of brain images is hugely enhanced by the information on the characteristics of 
individual subjects and the study in which they participated, but at present studies vary 
widely in what data they present on the study, subject or image data, and how these data are 
presented (Dickie et al., 2012).  
  
Only a small proportion of the images performed for research are included in biobanks, and  
in existing structural brain image biobanks, normal subjects over 60 years of age are 
relatively under-represented, with limited cognitive and medical metadata to support their 
classification as “normal” (Dickie et al., 2012), and available with a limited range of 
neuroimaging sequences. For example, fluid attenuated inversion recovery (FLAIR) and T2* 
volumes are often not available, although they are essential for sensitively identifying and 
quantifying white matter hyper-intensities (WMH) and microbleeds respectively, 
neuropathologies present in normal ageing but associated with vascular cognitive impairment 
(Wardlaw et al., 2013; Ritchie et al., 2016). Newer initiatives like BRAINS (Job et al., 2016) 
provide a range of sequences (e.g., T1, T2, T2*, and FLAIR) for most subjects plus cognitive 
and medical information. Future data sharing will be facilitated by influencing how new data 
are collected in terms of core imaging sequences and meta-data variables. 
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Standards for sharing: The INCF (International Neuroinformatics Coordinating Facility) 
Standards for Data Sharing Neuroimaging Task Force  the Brain Imaging Data Structure 
(http://bids.neuroimaging.io/) to advance standard organisation and descriptions of data files, 
and the Neuroimaging Data Model (http://nidm.nidash.org/) for data provenance tracking, but 
ongoing work is needed around developing community consensus and adoption of standards 
(Bjaalie and Grillner, 2007). Issues such as privacy, de-identification, quality control, 
provenance, avoiding including the same subjects in multiple databases, ethics (historical and 
future), consent, essential components of ‘good guardianship’, costs, sustainability, software 
version control, , definitions of ‘normality’, and international variations in ethical and legal 
frameworks, also need further consideration (Rodríguez González et al., 2010). The European 
Society of Radiology (ESR) published a position paper on Imaging Biobanks (European 
Society of Radiology, 2015) defining imaging biobanks, outlining their purpose, and 
advocating the creation of a network/federation of such repositories with existing biobanks. 
  
Many funders advocate or mandate that data generated by studies they fund are made public 
and the International Committee of Medical Journal Editors (ICMJE) has proposed that 
deidentified patient information is shared before research manuscripts of randomised 
controlled trials will be considered for publication (Taichman et al., 2016). While this data 
sharing may be relatively straightforward for tabular demographic data (i.e. the types of 
alphanumeric data that can be held in traditional databases), the situation is much more 
complex for brain image data (Toga, 2002, Marcus et al., 2007a). Factors like the size of 
imaging files and the possibility of identifying subjects from images impose non-trivial 
technological challenges. While initiatives such as NeuroVault (www.neurovault.org - 
Gorgolewski et al. 2015) avoid the problem by publicly sharing statistical maps for data 
aggregation it does not include whole datasets. By contrast, a repository like OpenfMRI 
(www.openfmri.org) includes raw-data, with some subject-level variables, which allows 
newer analyses to be performed. Even when there is a desire to share imaging data, there are 
a number of technical, legal and practical problems to be overcome: (Poline 2012; Poldrack 
and Gorgolewski, 2014, Pernet & Poline, 2015). 
  
2. Learning from existing databanks and population studies 
Against this background, a group of experts, including specialists in image acquisition and 
analysis, clinical disciplines, epidemiology, legal, ethics, and data science, met to discuss and 
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debate conceptual, legal, ethical and technical issues around creating brain image banks. We 
aimed to highlight the issues that need to be addressed, from the ethical to the practical, 
achieve some consensus, promote best practice and provide useful advice for ongoing and 
planned studies. The primary aim of the meeting was to encourage data sharing, construct 
pan-institutional brain image databank consensus, and facilitate linking between databanks. 
Here, we describe lessons learned from existing image databanks, provide advice on 
technical, epidemiological and legal challenges and identify areas where agreement was not 
reached that should be addressed as the field evolves. 
Representatives of major groups involved in neuroimaging databases were present at the 
meeting (Table 1). We recognise that there are other imaging databases, many summarised in 
recent publications (e.g. Sharing the Wealth: Brain Imaging Repositories in 2015; 
Neuroimage 124 Part B), but here we provide the lessons learned by this international group 
with experience in building databases and sharing data under various schemas, for healthy 
participants and people with neurological disorders, from prenatal to old-age. We noted that 
the information collected in each databank was very different depending on the perspective 
and expertise of  the individual, e.g. computer scientists or data analysts versus clinicians or 
epidemiologists.   
  
Table 1: Databases presented at brain image bank meeting with relevant references, 
website, and data access policy  
Data Base Website Data access policy 
ADNI (Weiner, 2015) 
ENIGMA (Thompson et 
al., 2015) 
  
http://adni.loni.usc.edu/ 
http://enigma.ini.usc.edu/ 
  
ADNI: registration and 
application for approval by 
steering committee for data 
access 
ENIGMA: data is shared 
between members on an ad 
hoc basis 
BRAINS (Job et al., 
2016) 
http://www.brainsimagebank.a
c.uk/ 
Open access search of 
available data; registration and 
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application for approval by 
steering committee for data 
access 
Dementia Platform UK 
(DPUK) 
  
http://www.dementiasplatform
.uk/ 
  
In development: online 
registration required 
Edinburgh Birth Cohort www.ebc.ed.ac.uk 
 
Online search of available 
data ; registration and 
application for approval by 
steering committee for data 
access via 
http://www.brainsimagebank.a
c.uk/ 
 
European Population 
Imaging Infrastructure 
Rotterdam study (Ikram 
et al., 2015 ; Hofman et 
al., 2015) 
Generation R (Jaddoe et 
al., 2012) 
http://populationimaging.eu/ 
http://www.erasmus-
epidemiology.nl/research/ergo
.htm 
http://www.generationr.nl/ 
Email contact for information 
on available datasets 
EVA, 3-CITIES, DBGIN, 
BIL&GIN, i-SHARE 
(Alperovitch et al., 2002; 
Lemaitre et al., 2005; 
Mazoyer et al 2016). 
http://www.gin.cnrs.fr/BILand
GIN 
http://www.three-city-
study.com/the-three-city-
study.php 
  
Registration and application 
for approval by steering 
committee for data access 
IMAGEN 
  
http://www.imagen-
europe.com/en/consortium.ph
p 
Registration and application 
for approval by steering 
committee for data access 
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Montreal Consortium for 
Brain Imaging Research 
(Evans et al., 2012). 
https://www.mcgill.ca/globalh
ealth/international-
consortium-brain-mapping 
  
Registration and application 
for approval by steering 
committee for data access 
OASIS (Marcus et al., 
2007b, 2009) 
Human Connectome 
Project (Van Essen et al., 
2013) 
http://www.oasis-brains.org/ 
http://www.humanconnectom
e.org/ 
  
OASIS: open access, no 
registration required 
HCP: open access with 
restricted access for sensitive 
data (registration and 
application for approval by 
steering committee) 
Rhineland study https://www.dzne.de/en/resear
ch/research-areas/population-
health-sciences/rhineland-
study.html 
Email contact for information 
on available datasets 
UK Biobank (Matthews 
& Sudlow, 2015) 
  
http://www.ukbiobank.ac.uk/ 
  
Open access search of 
available data; registration and 
application for approval by 
steering committee for data 
access 
  
Among the various problems that plague databases, the group identified four, which raise 
new questions not previously well addressed in the epidemiological community for 
neuroimaging: (1) data collection; (2) addressing data heterogeneity; (3) database 
infrastructure; and (4) database management.  These aspects marks major divisions that goes 
into building a databank (figure 1). Here, we discuss each of these aspects, presenting lessons 
learned and recommendations. 
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Figure 1. Major issues identified in building a brain image biobank (arrows indicate which 
aspects constrain each other)  
3. Data collection  
  
There is a great willingness from many people across the life course to volunteer for brain 
imaging studies: even when the participants are in their nineties and the study includes 
prolonged imaging (Deary et al., 2012). However, such willing individuals – irrespective of 
age – tend to be fitter, better educated and less socially deprived than the general population 
(e.g. Deary et al., 2012; Stafford et al., 2013). Extra effort is therefore needed to encourage 
more representative population sampling, or the consideration of statistical approaches to 
account for known bias (Ganguli et al., 2015). 
  
3. A. Subject sampling 
 
Several aspects of study design, fundamental to good epidemiology, are currently not 
prominent among brain image banks. The use of guidelines on study reporting should 
improve quality (http://equator-ntework.org). The method of subject selection (random, 
sequential, particular characteristics, etc.), population from which they were selected (e.g.  
hospital clinic attendees, primary care attendees, general population) and method (e.g. direct 
mailing, adverts, any compensation or payment) should be described clearly. In general, 
research participation varies with social class, education, health status, by ethnic and other 
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minority groups (Deary et al., 2012; Stafford et al., 2013), hence documenting the original 
study aims when data are collated for secondary use is important to describe the population. 
This can be achieved by citing a paper, ‘read me’ descriptors, or website that describes the 
original study, linked from the database. 
  
A subject should only contribute once to a particular analysis. However, several open datasets 
include the same individuals (Dickie et al., 2012) potentially distorting any results if several 
such databanks are used in one analysis. Methods are needed to identify if a subject is 
included in multiple studies. Identification of the uniqueness of a subject’s inclusion in a 
database is a significant problem, with few effective solutions at present. ‘Pseudo-
anonymised’ identifiers can identify individuals in longitudinal studies. Probabilistic 
matching of clinical or imaging data could identify repeat subjects if enough data were 
available – however this approach may not be reliable, and also implies that even de-
identified data about an individual cannot be considered truly anonymous, as data may be 
susceptible to data linkage attacks (Fung et al., 2010).  Simply asking participants about 
inclusion in other studies is unlikely to be reliable. Preferably, subjects would be assigned a 
unique study identifier linked to a unique study registration, but this is difficult to implement 
in practice, as there is no central database of studies. However, tools such as The Global 
Unique Identifier (GUID) may perform this function (https://data-
archive.nimh.nih.gov/rdocdb/s/guid/nda-guid.html). GUID is a universal subject ID which 
allows participants to be matched across labs and research data repositories, as well as 
allowing researchers to share data specific to a study participant without disclosing 
identifiable information. In genetic studies, it is sometimes possible to use a “checksum” 
method based on a person’s genomic data, to test whether any individuals took part in two 
studies being compared, as this may be important to avoid reporting spurious associations 
(Franke et al., 2016). 
  
Methods for long term follow up of healthy volunteers and adding linked data including 
health outcomes many years later, is potentially very valuable and should also be considered 
wherever possible (e.g. Deary et al. 2011; Matthews & Sudlow, 2015). 
 
3. B. Metadata collection 
Some studies include extensive socio-demographic data, others have detailed clinical 
characteristics and vascular risk factors, others focus on cognitive testing, and several have 
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extensive blood or urine biomarkers including genetics. A key aspect to consider is to define 
the minimum subject metadata to ensure maximum use of the data world-wide. 
  
Age, sex (self-report), handedness (self-report and/or Edinburgh inventory test) and 
education (total years of education and highest qualification) are important variables that 
should always be reported, because they are associated with brain structure and function: age 
(Dickie et al, 2012); sex and handedness (Good et al, 2001); and education (Cox et al, 2016). 
The detail in which variables are collected, and what other meta-information is required 
depends on the setting. In a clinical setting, ‘normal’ or healthy is often defined as above or 
below a cut-off, the definition may be somewhat arbitrary (e.g. blood pressure of 140/90; 
cognitive test score above a threshold; blood test value). In a research setting, the concept of 
‘normal’ may refer to healthy controls, who do not have the disease of interest (but may have 
other conditions) and meet several other criteria defined within the study. People recruited to 
a study because they are ‘healthy’ or ‘normal’ may have occult or undeclared disease, have 
borderline values (e.g. blood pressure of 138/88) or develop disease in the future. It is 
essential that those participating in a study are well-described if their data are to be used for 
other purposes. A balance needs to be struck between overburdening subjects, versus 
inadequate information. The method of collection of data (e.g. self-report of sex vs. 
chromosomal identification) will depend on the purpose and location of the original study, 
and description of the population is encouraged (e.g. educational system to allow 
international comparison). 
 
Further discussions are required to agree a minimum normative subject dataset, but this is 
likely to include some measure of sociodemographic variables, clinical features (main 
comorbidities, medications), cognitive ability (at least a general cognitive test). 
Availability of biomarkers (such as DNA) may also be useful. The potential to link to data 
collected for other reasons, such as participation in nationwide Biobanks or data collected 
during clinical care, may reduce the burden on participants if appropriate consent is provided 
and relevant reliable data are available. 
3. C. Consent 
Individuals must be informed and provide informed consent where possible. One issue is that 
it may be impossible to re-contact previous participants who have already provided consent 
for further use of their data, where imaging databanks were not specifically mentioned. In 
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such case, retrospective approval might be given by an ethics committee. More importantly 
for new studies, consent must include information on data reuse and sharing. The Open Brain 
Consent initiative (https://open-brain-consent.readthedocs.io/en/latest/) provides sample 
consent forms to allow deposition of anonymised data to public data archives, and a 
collection of tools to facilitate anonymization of neuroimaging data to enable sharing. This 
initiative aims to facilitate neuroimaging data sharing. It is based on the legal and ethical 
framework of the USA, but is adaptable to other countries.   
 
Individual projects should also decide whether there is a need to link subjects back to their 
anonymised data, and consent therefore must include information on being re-contacted. 
Individuals and researchers should be informed of who ‘owns’ the data (often the host 
institution: principal investigators should be aware of any restrictions if they move between 
institutions), if there are copyrights on images, and consent could be indicated in a metatag. It 
is also important to consider what should be done if data are collected from people without 
capacity to consent (e.g., children: if consent is provided by a parent on their behalf, can the 
child rescind this on reaching adulthood, and when should a young person be asked to give 
consent to ongoing participation in a longitudinal study that his / her parent consented to 
during the child’s infancy). 
3. D. Practical consideration in collecting MRI scans across the lifespan 
Perinatal: Data from healthy ‘normal’ fetuses throughout gestation and neonates born at term 
are currently sparse. Single centres have generally developed repositories to study specific 
cohorts (e.g. congenital heart disease or preterm neonates), using bespoke processing 
pipelines or pipelines developed using adult data but optimised for neonates (Boardman et al., 
2006; Miller et al., 2007; Ball et al., 2010; Serag et al., 2016). There are some fetal and 
neonatal structural MRI atlases (for example: Gousias et al., 2012; Shi et al., 2011; Blesa et 
al., 2016; Makropoulos et al., 2016; Kabdebon et al., 2014; Oishi et al., 2011), but to our 
knowledge there are no perinatal image banks hosting normal data acquired from multiple 
studies and sites. A perinatal sub-section of the BRAINS database is under development, and 
the developing Human Connectome Project (http://wp.doc.ic.ac.uk/dhcp/) aims to make data 
available from 1500 fetuses and newborns between 20-44 weeks’ post-menstrual age. 
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Experience from perinatal brain repositories is that newborn neuroimaging research is 
acceptable to parents and carers, especially those with children at risk of long term 
impairment. Newborns, including those who require intensive care, can be looked after safely 
in the MRI environment (Merchant et al., 2009). Research quality data can be acquired from 
infants without the use of sedation by using feed-and-wrap techniques, and by allowing 
flexibility within in the scan schedule to allow for coaxing to sleep and managing 
wakefulness. Perinatal image data are readily contextualised by maternal, pregnancy and 
birth information, and it can be analysed with information from infant biosamples (Boardman 
et al., 2014; Sparrow et al., 2016) and standardised childhood neurodevelopmental / cognitive 
outcome tests (Woodward et al., 2006): achieving prospective consensus over minimum 
datasets in these domains will maximise opportunities of perinatal data-sharing in future 
initiatives. 
 
Older age: Normal ageing is associated with increasing variability in brain structure, such as 
brain tissue loss (atrophy) and the accumulation of white matter hyper-intensities, which may 
or may not have functional impact on cognition, mood, gait etc. (Dickie et al., 2015a). Many 
brain image biobanks were created to study pathological ageing, e.g. dementia, and only 
small numbers of ‘healthy’ older people were previously included in accessible databanks 
(Dickie et al., 2012), making it difficult to define ‘normal ageing’ or pathological ageing.  
The availability of data from UK Biobank (http://www.ukbiobank.ac.uk/) and other ongoing 
population imaging initiatives in North America and mainland Europe will change this. One 
conclusion from the workshop was that, for databanks to accurately represent the spectrum of 
health, a large number of participants, sampled in equal numbers across appropriate age 
bands are required, accompanied by detailed descriptions of the demographic and clinical 
characteristics of individuals. 
4. Addressing Data heterogeneity 
Where more than one study is included in a brain image bank, like 3-CITIES (Alperovitch et 
al., 2002) or BRAINS (Job et al., 2016), there is usually substantial heterogeneity of the 
acquired demographic/clinical and imaging data. This can be addressed either by describing 
each variable (3-CITIES), or by harmonising metadata (BRAINS). Having many variables 
makes the database large and difficult to search, while transforming variables to agreed 
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standards, which is simpler for the end user, is resource intensive and requires additional data 
provenance documentation. Alternatively, in approaches such as ENIGMA (Thompson et al., 
2015) and UK Biobank  (Matthews and Sudlow, 2015), both raw and derived data from each 
of the participating centres can be used for large scale analyses: either in meta-analyses, 
which can circumvent issues of data sharing and transfer between countries, but may restrict 
the analyses that can be performed; or in ‘mega’-analyses using original data, which may be 
difficult to access due to data access controls, and/or too different to combine. Choosing the 
right framework clearly depends on the question(s) the database aims to address, and requires 
collaboration between local data providers and the databank.  
  
4. A. Minimum provenance of study data 
Brain imaging uses indirect measures to make inferences about brain structures. The 
meaningfulness of these measures will vary with the amount and heterogeneity of the data. 
The version of scanner and software used for data collection and analysis should be clearly 
documented.  Decisions need to be made about the inclusion of raw or processed data in the 
database, recording of processing steps, and whether outputs of imaging data will be raw, 
pre-processed or fully processed. The amount of data storage required for imaging (and e.g. 
genetic) data may require the use of high performance networking, storage and computing, 
which can be upgraded without compromising the database, adequate bandwidth, and/or the 
use of cloud computing, taking account of privacy and security issues (Poldrack 2014).  
 
Data provenance (study, aims, date performed, funders, principal investigator, recruitment 
method, publications) is important for appropriate citation and recognition of data sources, 
encouraging reproducibility, avoiding duplicates, and data versioning. This information can 
easily be documented on a per study basis without complex tools, though formal 
representation will maximise the potential for reuse.  For example, the W3C-PROV 
specifications is a framework to interchange provenance information 
(http://www.w3.org/TR/prov-dm/), and its extension for neuroimaging, NIDM 
(http://nidm.nidash.org - Keator et al., 2013), provide a way to encode provenance in a 
machine-readable manner. The European Human Brain Project 
(https://www.humanbrainproject.eu/en_GB) is also developing guidance on best practice for 
data mapping and sharing. 
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From a technical perspective, it is important that image related information are all recorded 
and shared. The Organisation for Human Brain Mapping recently provided a consensus list 
of reporting items (which can be a useful starting point for collecting and harmonising site-
specific information on imaging data (see appendix D, especially table D2 - 
http://www.humanbrainmapping.org/COBIDAS; Nichols et al., 2016). 
 
4. B. Role of Ontologies 
To allow comparisons between banks, many groups are now working on methods to compare 
clinical and imaging variables, and using appropriate ontologies. General standards can be 
found in the NIH’s Common Data Elements (http://cde.nih.gov/), an attempt to collect 
terminologies across biomedical practice. Building on PROV-DM 
(http://www.w3.org/TR/prov-dm/) - a World Wide Web Consortium standard to describe 
provenance - a Neuroimaging Data Model (NIDM) has been developed by the Standards for 
Data Sharing Neuroimaging Task Force of the International Neuroinformatics Coordinating 
Facility (Keator et al., 2013) to provide a unified framework on image format, names and 
image meta-data. XCEDE (XML-extensible markup language-based Clinical and 
Experimental Data Exchange: Gadde, 2012) provides general standards for data management, 
but specific terms must also be used. Subjects’ metadata are much more difficult to describe 
and cognitive tasks can be particularly difficult to aggregate or compare meaningfully. A 
recent attempt to describe them has been made in the Cognitive Paradigm Ontology (Turner, 
2012) or the Cognitive Atlas (Poldrack et al. 2011). It is important that the databank clearly 
describes which ontology was used, how decisions were made, and that all metadata variables 
are clearly defined.  
 
5. Database infrastructure  
Many of the studies that led to the creation of imaging databanks started over a decade ago, 
and reported issues relating to changing technology (Mazziotta et al., 2001). For example, 
technical staff need to consider the impact of hardware changes (e.g. upgrading or changing 
scanner software or hardware; changes in data storage solutions and formats) and software 
evolution, which can make keeping track of multiple analyses of the database challenging 
(Poldrack, 2014). Such changes in technology have, for instance, been shown to impact on 
local brain volume (Lorio et al., 2016) and atrophy measurements (Leung et al., 2015). 
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Changing requirements for data governance and data management also need to be considered: 
file names and structures may need to be updated to newer recommendations such as BIDS 
(Brain Imaging Data Structure) (Gorgolewski et al., 2015). Similarly, better understanding of 
disease aetiology, or changes in taxonomy, may affect how clinical characteristics are coded, 
and therefore what a database entry means, e.g. changing definitions of dementia subtypes. 
Studies may be cross-sectional or longitudinal. In studies of development or ageing, 
longitudinal data are particularly valuable (Mills and Tamnes, 2014), and systems need to be 
in place to ensure that future data acquisition can be matched to the correct subject, and that 
imaging parameters are similar enough to allow comparison. 
5. A. Technical infrastructure 
To maximize usage and usability, any planned databank should make use of a formal imaging 
database tools. We considered five software tools that create sharable, searchable databases 
and offer maximum flexibility: COINS (http://coins.mrn.org/) (Landis et al, 2016); LORIS 
(http://mcin-cnim.ca/neuroimagingtechnologies/loris/) (Das et al 2012); NiDB 
(https://github.com/gbook/nidb); Scitran (http://scitran.github.io/); and XNAT 
(http://www.xnat.org/) (Marcus et al, 2007a). The ability to link and search make those 
applications different from repositories; however each has strengths and limitations, some 
significant. Information reported below reflect user experience and discussion with software 
developers. 
Each of these different software tools has different strengths, discussed at the meeting.  
Comparing first the aspects related to the nature and format of imaging data, all of the above 
software tools support the Digital Imaging and Communications in Medicine (DICOM - 
http://dicom.nema.org/) format and can interface directly with scanners. Some software tools 
support almost any other image formats (COINS, NiDB, XNAT), while others are restricted 
to specific ones (LORIS, Scitran). Only XNAT has an explicit tool to link the data from the 
database directly to clinical PACS (Picture Archiving and Communication System), i.e. 
allowing direct transfer between the database and the health care service. As imaging is just 
one facet of any research study, it is vital that all these tools also allow storing of non-MRI 
data such as demographic, clinical, behavioural, and genetic data. Other types of data such as 
electroencephalography can be stored but may not be viewable using imaging 
analysis/display interfaces, and may require additional software. 
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Another important aspect to consider relates to the software: (1) How are MRI data linked 
with other types of data? (2) How can the data be visualised?; and (3) How can the data be 
explored? Linkage (bringing together datasets) is an important aspect to consider regarding 
the size of the dataset and its utility. For instance, LORIS is built with two distinct databases 
(imaging vs non-imaging) that allows the user to interrogate, process and retrieve information 
separately or together. XNAT uses an XML-defined schema for searching data, and also uses 
and underlying object-relational database PostgreSQL. Like LORIS, this allows searching 
and accessing data separately. Considering the end-user perspective of the database one 
wishes to build, all five tools allow one to search for image data within and across projects 
and to visualise data, though with some restrictions depending on the software. 
The final important aspects to consider are the overall maturity, usability, maintainability, 
extensibility and support of the software and access control. LORIS and XNAT, for 
instance, are well established and maintained, while newcomers (COINS, Scitran, NiDB) are 
more adapted to new data types and use more recent software technology. Mostly, the 
software can be installed with minimal programming expertise – but this differs between 
tools. Setting up multiple access control levels, linking or adding new functionalities, can 
however require much more expertise. For instance, XNAT, the most widely used platform, 
requires programming expertise to enable its extensible XML structure. In contrast, simpler 
tools with extensive search solutions exist (e.g. LORIS, NiDB), but modifying the search tool 
to suit dedicated needs also requires dedicated programming expertise. In terms of usability, 
it is worth considering data visualization, and whether the pipeline includes data quality 
control or basic data pre-processing. All the platforms considered include such options but 
various levels of programming expertise are required. It is important to also consider ‘future-
proofing’ the technology, at a minimum ensuring accurate version control, and direct access 
to code. Another essential aspect to consider is access control: COINS, LORIS, Scitran, 
XNAT have extensive security levels to create, read, and edit data, while NIDB is limited to 
user/project management. Thus, at present, the consensus was that there is no ‘best’ software, 
the field is moving rapidly, and it is worth considering every aspect discussed here with 
expert advice to choose a software tool that best suits specific needs. 
 
5. B. Security 
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A brain scan is unique, and could allow identification of the individual (e.g. by someone who 
already holds a copy of their brain image). There is a trade-off between removing all potential 
identifiers and retaining the scientific value of the data. Clear processes are required 
regarding  sensitive, or potentially identifiable, data to ensure that all reasonable safeguards 
are put in place, e.g. the DICOM Confidential software; completely removing all textual 
personally identifiable information; generating new “anonymous” identification numbers; 
“defacing” brain MRI (Marcus et al., 2007b, Milchenko and Marcus, 2013; Rodriguez, 2010). 
A balance between accessibility and security is important, ensuring that potentially 
identifiable data (text or images) are protected from remote access in the database and if 
released for external use. It should be clear to the intended users what the data are, and what 
will be the safeguards to access. To test whether data can be hacked, a mock database can be 
developed, released and attempts made to infiltrate the security systems. 
  
5. C. User interface 
The user interface should suit the main proposed users. The requirements of clinicians, 
researchers, or industry are however likely to be very different (for instance searching per 
pathology vs. scan feature, looking for raw vs. processed data). It is worth considering the 
user interface and its design. In XNAT for example, the level of detail displayed to users can 
be made dependent on both their relationship with the databank (external user, contributor, 
etc.) and/or the intended use of the data of interest (Marcus et al., 2007a). The use of an 
Application Program Interface (API) allows for easier creation and customisation of user 
interfaces for different user groups, but can bring new security concerns. 
5. D. Data release 
In ongoing/longitudinal studies, there is a wide variation in when data are released: as 
collected, in batches, on completion, or after all analyses performed by initial research team. 
There is currently no consensus on how to release data, but it is important to make that 
decision clear and have mechanisms in place to identify releases (data version control). 
Primary researchers who developed the database should apply through the same mechanism 
once the databank is public. 
5. E. Quality assurance and control of data 
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Quality assurance (QA) of all data is key to providing high quality and robust research 
findings (Ducharme et al., 2016). All QA steps of data collection (blinding of researchers, 
checking of data entry, standard operating procedures and calibration of equipment, 
particularly methods such as phantom scanning to describe scanner stability) should be 
recorded and provided with the data. Quality control should be implemented at all stages of 
the database from provenance to visualization. Data aggregation centres could provide a 
useful service with a common QC procedure across all datasets included. An important step 
is to be transparent on how this is implemented and what is tested on the data. If it is planned 
to incorporate processed data from external groups (e.g. templates, feature measures, etc.), 
how will the quality control be implemented? With increasing open access and secure web-
based repositories, one option is to link to such repositories rather than incorporating 
secondary data into the database. This encourages early sharing of secondary (summary) data 
without the need to request access to the original databases (the model being pursued by UK 
Biobank) that have more stringent safeguards and comprehensive data access agreement to 
control research usage. 
 
6. Database management  
The legal and ethical framework of individual countries, and agreements reached between 
them, may affect how and where data are or can be stored. Systems are required to ensure 
data security, but allow appropriate access. Relevant approvals should be transparent, e.g. in 
publications and on websites.  
 
During the meeting it was recognized that brain image databanks should have a Steering 
Committee, including independent and lay representatives, to monitor and review progress. 
This has the advantage of providing oversight of data usage and the opportunity to review 
data requests, but can be time consuming, it may be difficult to get agreement among 
stakeholders, and therefore delay access to data, and it can be difficult to identify lay 
representatives. Consideration should be given to how ‘sleuthing’ of individual’s data can be 
minimised or prevented, and to the legal and ethical aspects of data collection, storage and 
sharing. This is relevant both for adult and perinatal studies (for both mother and baby). 
Decisions need to be made in advance about what will happen to data if an individual decides 
to opt out; loses capacity in the future (e.g. develops dementia); or gains capacity to make his 
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or her own decisions (e.g. a child growing up). Decisions should be able to be reviewed by 
the steering committee if legal or ethical frameworks change. 
 
6. A. Legal and ethical issues 
The legal framework may vary between countries, and this should be considered in 
international collaboration. The general principle is that researchers should satisfy the 
governing body, e.g. ethics committee, which they are processing and dealing with people’s 
data responsibly. It is useful to consider the concept of a ‘motivated intruder’: have 
reasonable steps been taken to protect data from someone making attempts to access the data. 
  
Factors such as what will be done to divulge findings of abnormalities found on 
neuroimaging (e.g. tumours, or features of cerebrovascular disease, or multiple sclerosis) 
should be considered (Wardlaw et al., 2011; Wardlaw et al., 2015). Some primary studies 
have all scans evaluated by a neuroradiologist, others explicitly state that no feedback will be 
given on any tests. The issue for databanks is what to do if an abnormality of potential health 
significance is noted, or new health implications for existing findings come to light during 
secondary use – should the information be fed back to the participant, or the researchers that 
produced the data? These issues should be considered in the data donation agreement. If data 
are fully anonymised such feedback would not be possible. 
  
The UK Health Research Authority (http://www.hra.nhs.uk/) is one example of a body that 
promotes research to improve clinical care of patients. The sharing and use of already 
collected data with appropriate safeguards fits this duty. The Royal Society, Science as an 
Open Enterprise, (2012) report, promotes Intelligent Openness – intelligibility, verifiability, 
accessibility if robust, if there is commercial confidence and personal privacy. 
 
6. B. Publication 
To maximise use, databanks should be registered on a publicly accessible registration 
website. Currently there is no international registry for neuroimaging studies or databanks. A 
general platform such as ClinicalTrials.gov could be used in the interim.  One option would 
be a data posting website for imaging, like dbGaP for genetics 
(http://www.ncbi.nlm.nih.gov/gap). Researchers should be encouraged to publish a ‘protocol 
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paper’ which records how the databank was established, and the decisions made at each stage 
(e.g. for UK Biobank at http://www.ukbiobank.ac.uk/wp-content/uploads/2011/11/UK-
Biobank-Protocol.pdf) and a ‘data paper’ that can include technical data and then be cited in 
the methods section of future results papers (e.g. for the imaging in UK Biobank 
http://www.nature.com/neuro/journal/v19/n11/full/nn.4393.html). The wording on citation 
and authorship should not contravene ICJME (International Committee of Medical Journal 
Editors) rules http://www.icmje.org/recommendations/browse/roles-and-
responsibilities/defining-the-role-of-authors-and-contributors.html. There is also the 
possibility of having a Research Resource Identifier (RRID – Bandrowski et al., 2015). The 
consensus from our meeting was to discourage authorship, but to have the data paper cited 
along with the inclusion of the databank acronym with a web-reference or, better still, a DOI. 
A standardised template for reporting these papers (such as CONSORT for randomised 
controlled trials, see http://www.equator-network.org/) would be useful. This would allow an 
emphasis on clinical and epidemiological as well as technical perspectives. 
 
6. C. Funding 
Increasingly, funders are keen to encourage data sharing; indeed some go so far as to refuse 
future funding unless the results of prior funded studies have been published open source 
(http://www.wellcome.ac.uk/About-us/Policy/Policy-and-position-
statements/WTD002766.htm). While most brain imaging studies are individually funded 
through grants to acquire data and undertake initial analyses, it has previously been difficult 
to obtain funding to create a brain image bank, or if initial funding was secured, then it may 
be insufficient to maintain the database long term, and deal with data requests. Storage and 
back up is, however, necessary, and inclusion for provision of this is encouraged. Researchers 
at ADNI estimate that 10-15% of funding, and 15% of time has been spent on data sharing 
(Wilhelm et al., 2014). The use of large-scale distributed computation can make the work 
more efficient, but users need to be aware of the heterogeneity of the constituent datasets e.g., 
in ENIGMA no one national government had to finance all the capital infrastructure. 
Similarly, a distributed image databank could be supported by funding from individual 
countries, much as are some multinational clinical trials. There is a tension between the desire 
to share the data and the feasibility of actually affording to do so, and a range of models exist. 
One model of cost-recovery used in UKBiobank (http:www.ukbiobank.ac.uk) is a fixed 
charge for reviewing the application, and a variable component depending on the data 
requested. 
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Some organisations, such as DataLad (http://datalad.org/) have developed infrastructure to 
provide access to scientific data available from various sources (e.g. lab or consortium web-
sites or data sharing portals) through a single interface and integrated with software package 
managers  
 
  
 
  
 
 
  
  
  
 
  
Conclusions 
Brain image biobanking is a rapidly evolving field. Several related and relevant projects will 
complement our recommendations, such as the International Neuroinformatics Coordinating 
Facility (INCF) Neuroimaging Data Sharing Task Force 
(wiki.incf.org/mediawiki/index.php/Neuroimaging_Task_Force) meeting held at Stanford 
University on January 27-30th 2015, which led to the development of the Brain Imaging Data 
Structure (BIDS - http://bids.neuroimaging.io/, Gorgolewski et al., 2016). 
  
A federated international network of normative brain image biobanks is achievable (see table 
2) and would have many advantages, including: 1) facilitating large scale meta-analyses of 
brain structure and function, in health and disease, following successful precedents (e.g. 
genetics – Hibar et al., 2015; depression – Schmaal et al., 2016; schizophrenia – van Erp et 
al., 2016; bipolar disorder – Hibar et al., 2016); 2) avoiding duplication of effort by data re-
use, as occurs widely in physics; 3) providing population controls; 4) increasing research 
efficiency where research questions could be answered using existing data; and 5) providing 
a mechanism to replicate results in different demographic populations. The barriers to 
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achieving this vision are political, ethical, technical, and financial, but a federated 
international group could work with funders, legal and ethical experts and industry along the 
lines of the solutions proposed here.  Most large scale recent initiatives are still within 
geographical regions (e.g. the Obama BRAIN initiative; the European Human Brain Project), 
with some exceptions, such as the ENIGMA initiative spanning 35 countries (Thompson et 
al., 2015). Truly global, inter-regional initiatives are needed, to make full use of 
neuroimaging to understand the brain across the life-course. 
  
  
  
  
  
 
Table 2. Action points for global data sharing via brain image databanks 
  
Key issue Reason Suggested action 
Data provenance unclear Establish if results relevant 
for user’s population 
Clear data provenance tagged 
to each data item e.g. W3C-
PROV 
Acknowledge role of 
original studies, and 
databanks 
Ensure clear recognition 
and ownership of data 
Data use agreement templates 
should be published, and 
shared between databanks 
Ensure appropriate 
informed consent 
Define whether data 
storage, sharing and future 
use is permitted 
Ethical committee review of 
applications, share consent 
templates between databanks 
Oversight of databank Appropriate use of data, 
data sharing 
Studies should have a steering 
committee, with independent 
oversight, and consider 
legal/ethical/lay members 
Variation in data collected Difficult to share data, Agree minimum dataset (e.g. 
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compare results sex, age, handedness), and 
ontology (e.g. NIDM from 
INCF; BIDS) 
Subject duplication Avoid multiple entries 
from single individual 
Global register of image 
banks; (or use brain image or 
genome as an identifier) 
Databank changes with 
time 
Unsure what data were in 
databank when analyses 
performed 
Database version included 
with database; data accessed 
and study ID for included 
subjects provided for 
published papers 
Volume of data Need secure methods for 
data sharing 
Safe Havens or Virtualization 
Desktop Infrastructure 
Longevity of databank Changes in hardware and 
software for imaging, data 
entry and storage 
Involve technical experts in 
design, regular back up, 
including to remote location 
Longevity of databank Data storage, and sharing, 
as required by most 
funders of original projects 
Funding required for database 
management and storage, and 
allowing open access 
Large numbers of 
databanks 
Can be difficult to find. 
Analysis of already-
collected data may reduce 
research waste, compared 
to conducting new study 
Register database e.g. on 
clinicaltrails.gov, or set up a 
register of brain imaging 
databases; early publication of 
protocol or data paper 
Variability in databanks Designed for wide range of 
purposes, may be used for 
other secondary aims 
Standardised reporting 
guidelines for papers 
describing brain image 
databanks (such as 
CONSORT for randomised 
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controlled trials, see 
http://www.equator-
network.org/ ) 
Authorship Papers that use data from 
brain image databanks but 
where databank staff are 
not involved in writing the 
paper 
Establish different authorship 
categories (as done for trials); 
reference to protocol or data 
paper 
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